Home Cart Sign in  
Chemical Structure| 600-21-5 Chemical Structure| 600-21-5

Structure of N-DL-Me-Ala-OH
CAS No.: 600-21-5

Chemical Structure| 600-21-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: H-N-Me-DL-Ala-OH; N-Methyl-DL-alanine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 600-21-5 ]

CAS No. :600-21-5
Formula : C4H9NO2
M.W : 103.12
SMILES Code : CC(NC)C(O)=O
Synonyms :
H-N-Me-DL-Ala-OH; N-Methyl-DL-alanine
MDL No. :MFCD00063136
InChI Key :GDFAOVXKHJXLEI-UHFFFAOYSA-N
Pubchem ID :4377

Safety of [ 600-21-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 600-21-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 7
Num. arom. heavy atoms 0
Fraction Csp3 0.75
Num. rotatable bonds 2
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 25.92
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

49.33 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.98
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-2.49
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.32
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-2.61
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.67
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-1.02

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

1.22
Solubility 1720.0 mg/ml ; 16.6 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

2.0
Solubility 10200.0 mg/ml ; 99.3 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.06
Solubility 90.9 mg/ml ; 0.881 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-8.7 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

3.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.19

Application In Synthesis of [ 600-21-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 600-21-5 ]

[ 600-21-5 ] Synthesis Path-Downstream   1~42

  • 1
  • [ 7464-68-8 ]
  • [ 600-21-5 ]
  • 2
  • [ 112-16-3 ]
  • [ 600-21-5 ]
  • [ 111389-50-5 ]
  • 3
  • [ 57658-79-4 ]
  • [ 871885-96-0 ]
  • [ 600-21-5 ]
  • 5
  • [ 64-17-5 ]
  • [ 600-21-5 ]
  • [ 56428-90-1 ]
  • 6
  • [ 600-21-5 ]
  • [ 420-04-2 ]
  • [ 76146-28-6 ]
  • 8
  • [ 600-21-5 ]
  • [ 27646-78-2 ]
YieldReaction ConditionsOperation in experiment
61% With lithium aluminium tetrahydride; In tetrahydrofuran; at 70℃; for 16h; To a solution of 2-(methylamino)propanoic acid (10.0 g, 96.97 mmol) in THF (200 mL) wasadded LiAIH4 (5.52 g, 145.46 mmol) portionwise. The mixture was heated to 70 C for 16 h.After cooling the reaction to room temperature, water (10 mL) was added. The mixture was filtered and concentrated in vacuo. The crude residue was washed with HCI/EtOAc (2 M, 50 mL) to give the title compound (5.3 g, 61%) as a brown oil that required no fartherpurification. ?H NMR (400 MHz, CD3OD) 6 3.81 - 3.78 (m, 1H), 3.56 - 3.51 (m, IH), 3.26 -3.22 (m, IH), 2.68 (s, 3H), 1.28 (d,J= 7.2 Hz, 3H).
  • 9
  • [ 600-21-5 ]
  • [ 100-52-7 ]
  • [ 90-82-4 ]
  • [ 90-81-3 ]
  • 10
  • [ 600-21-5 ]
  • [ 98-88-4 ]
  • [ 69994-40-7 ]
  • 11
  • [ 600-21-5 ]
  • [ 103-71-9 ]
  • [ 2221-10-5 ]
  • 12
  • [ 600-21-5 ]
  • [ 75-07-0 ]
  • [ 107-89-1 ]
  • 13
  • [ 600-21-5 ]
  • [ 79-22-1 ]
  • [ 51784-00-0 ]
  • 16
  • [ 74-89-5 ]
  • [ 535-13-7 ]
  • [ 600-21-5 ]
  • 17
  • [ 74-89-5 ]
  • [ 535-11-5 ]
  • [ 600-21-5 ]
  • 18
  • [ 600-21-5 ]
  • [ 112-67-4 ]
  • <i>N</i>-methyl-<i>N</i>-palmitoyl-alanine [ No CAS ]
  • 19
  • [ 1070-19-5 ]
  • [ 600-21-5 ]
  • [ 13734-31-1 ]
  • 20
  • [ 600-21-5 ]
  • [ 13328-69-3 ]
  • [ 21654-65-9 ]
  • 21
  • [ 600-21-5 ]
  • [ 67309-82-4 ]
  • 22
  • [ 600-21-5 ]
  • [ 40162-09-2 ]
  • 23
  • [ 600-21-5 ]
  • [ 420-04-2 ]
  • [ 35404-52-5 ]
  • 24
  • [ 98026-07-4 ]
  • [ 600-21-5 ]
  • 25
  • [ 127-17-3 ]
  • [ 103-67-3 ]
  • [ 600-21-5 ]
  • 26
  • [ 600-21-5 ]
  • [ 501-53-1 ]
  • [ 91738-83-9 ]
  • 27
  • [ 600-21-5 ]
  • [ 79-04-9 ]
  • [ 24463-58-9 ]
  • 28
  • [ 74-89-5 ]
  • [ 598-78-7 ]
  • [ 600-21-5 ]
  • 29
  • [ 600-21-5 ]
  • [ 7677-24-9 ]
  • [ 127381-09-3 ]
  • 30
  • [ 600-21-5 ]
  • [ 65211-53-2 ]
  • [ 120801-39-0 ]
  • 31
  • [ 590-28-3 ]
  • [ 600-21-5 ]
  • [ 77220-27-0 ]
  • 32
  • [ 600-21-5 ]
  • [ 50-00-0 ]
  • [ 75-07-0 ]
  • [ 302-72-7 ]
  • [ 74-89-5 ]
  • 34
  • [ 32012-16-1 ]
  • [ 600-21-5 ]
  • 35
  • [ 600-21-5 ]
  • [ 108-24-7 ]
  • [ 70717-18-9 ]
  • 36
  • [ 600-21-5 ]
  • [ 97-72-3 ]
  • [ 70717-17-8 ]
  • 37
  • [ 600-21-5 ]
  • [ 103-71-9 ]
  • [ 2221-10-5 ]
  • [ 102-07-8 ]
  • 38
  • [ 600-21-5 ]
  • [ 123-62-6 ]
  • [ 70717-16-7 ]
  • 39
  • [ 600-21-5 ]
  • [ 624-83-9 ]
  • [ 80029-12-5 ]
  • 40
  • [ 600-21-5 ]
  • [ 57711-36-1 ]
  • [ 97248-97-0 ]
  • 41
  • [ 50-00-0 ]
  • [ 600-21-5 ]
  • [ 623-47-2 ]
  • [ 68384-73-6 ]
  • [ 137569-77-8 ]
  • 42
  • [ 600-21-5 ]
  • [ 100-51-6 ]
  • N-methylalanine benzyl ester hydrochloride [ No CAS ]
 

Historical Records

Categories